Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN1260345A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1260345A discloses novel hydrazide compounds targeting NPY receptors for obesity treatment, offering robust synthesis routes and supply chain advantages for API manufacturing.